glp-1 receptor agonist after roux-en-y gastric bypass A Comprehensive Review on Weight Gain following Discontinuation of Glucagon‐Like Peptide‐1 Agonists for Obesity - Abdullah bin Ahmed - 2024 - Journal of Obesity Interest in Treatment with GLP-1

It may help to think of our gut microbiome as a wild garden that provides us with natural medicines and foods

Van Opdenbosch N, Lamkanfi M

Glutathione S-Transferase, GST, Glutathione S-transferase class-mu 26 kDa isozyme, GST 26, Sj26 antigen, SjGST

These medications were originally developed for type 2 diabetes management but have demonstrated substantial weight loss effects in clinical trials and real-world use

Additionally, there is a controlling role of the pentadecapeptide BPC 157 against the tumor-promoting effects of many growth factors and peptides (Sikiric et al., 2018) as well as counteracting harmful escape from the initial healing effect (i.e., angiogenesis)